Skip to main content

Advertisement

Table 1 Clinical and laboratory parameters of RA patients enrolled in the current study

From: A novel gene-expression-signature-based model for prediction of response to Tripterysium glycosides tablet for rheumatoid arthritis patients

Parameters Discovery cohort (n = 12) Validation cohort (n = 31)
Age (years, mean ± SD) 55.9 ± 10.4 57.9 ± 12.0
Gender (male/female) 2/10 8/23
Disease duration (months, mean ± SD) 36.5 ± 30.6 41.5 ± 21.5
Erythrocyte sedimentation rate (ESR, mm/H, mean ± SD) 58.4 ± 21.3 40.5 ± 27.3
C-reactive protein (CRP, mg/dL, mean ± SD) 25.6 ± 22.9 21.5 ± 36.7
Positive rheumatoid factor (n, %) 10, 83.3 24, 77.4
Positive anti-cyclic citrullinated peptide (CCP) antibodies (n, %) 9, 75 24, 77.4